4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001144204-19-035234
Options or other derivatives
- Chief Medical Officer acquired 160,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GRAF FINCKENSTEIN FRIEDRICH · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-07-18 | Grant or award : show line 1 in the form Stock Option (right to buy) | +160,000 | $25.78 | 2029-07-17 | 160,000 | 160,000 | D |
Loading xslF345X03/tv525514_4.xml…